IL6 and congenital rubella syndrome: While it was found that COS treatment at dosage of 5 μM did not affect the elevated protein level of IL-6 and tumor necrosis factor-α (TNF-α) induced by CRS (Supplementary Fig. S5a–c), which is similar with previous study [60].